Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor
- 7 November 2005
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 79 (1), 133-139
- https://doi.org/10.1189/jlb.0805447
Abstract
Pulmonary alveolar proteinosis (PAP) is an anti-granulocyte macrophage-colony stimulating factor (GM-CSF) autoimmune disease resulting in the accumulation of phospholipids in the alveoli. GM-CSF knockout (KO) mice exhibit a strikingly similar lung pathology to patients with PAP. The lack of functionally active GM-CSF correlates with highly elevated concentrations of M-CSF in the lungs of PAP patients and GM-CSF KO mice. M-CSF has been associated with alternative macrophage activation, and in models of pulmonary fibrosis, M-CSF also contributes to tissue resorption and fibrosis. Matrix metalloproteinase-2 (MMP-2) and MMP-9 have been implicated in extracellular matrix degradation in animal models of fibrosis and asthma. We show for the first time that the lungs of PAP patients contain highly elevated levels of MMP-2 and MMP-9. PAP broncholaveolar lavage (BAL) cells but not bronchial epithelial cells expressed increased MMP-2 and MMP-9 mRNA relative to healthy controls. Both MMPs were detectable as pro and active proteins by gelatin zymography; and by fluorometric global assay, PAP–MMP activity was elevated. BAL cells/fluids from GM-CSF KO mice also demonstrated significantly elevated MMP-2 and MMP-9 gene expression, protein, and activity. Finally, PAP patients undergoing GM-CSF therapy exhibited significantly reduced MMPs and M-CSF. These data suggest that in the absence of GM-CSF, excess M-CSF in PAP may redirect alveolar macrophage activation, thus potentially contributing to elevated MMP expression in the lung.Keywords
Funding Information
- National Institutes of Health (HL67676, AI055840)
This publication has 49 references indexed in Scilit:
- Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppressionClinical Immunology, 2005
- Asthma: Mechanisms of Disease Persistence and ProgressionAnnual Review of Immunology, 2004
- Anti-GM-CSF Titer Predicts Response to GM-CSF Therapy in Pulmonary Alveolar ProteinosisClinical Immunology, 2002
- GM-CSF Regulates Alveolar Macrophage Differentiation and Innate Immunity in the Lung through PU.1Immunity, 2001
- Pulmonary Alveolar Proteinosis Is a Disease of Decreased Availability of GM-CSF Rather than an Intrinsic Cellular DefectClinical Immunology, 2000
- Rare diseases bullet 6: Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesisThorax, 2000
- Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxideAnnals of Allergy, Asthma & Immunology, 1999
- M-CSF: HAEMATOPOIETIC GROWTH FACTOR OR INFLAMMATORY CYTOKINE?Cytokine, 1998
- Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice.JCI Insight, 1996
- Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary HomeostasisScience, 1994